Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1Phase 3 1Phase 2 1Phase 1 1

Status

Completed 40Terminated 6Unknown 5Active not recruiting 4Recruiting 2Withdrawn 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Polycystic Ovary Syndrome 2

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Flutamide × Clear all
NCT00930228 2023-11-02

CRM004

University of Virginia

Phase 1 Unknown
72 enrolled

Polycystic Ovary Syndrome

NCT04597099 2023-11-02

CRM010

University of Virginia

Phase EARLY_PHASE1 Unknown
10 enrolled

Polycystic Ovary Syndrome

NCT04248621 2021-07-29

Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients

Wonju Severance Christian Hospital

Phase 4 Unknown
164 enrolled
Genitourinary

Prostatic Neoplasms

NCT02742675 2020-07-07

Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)

Fudan University

Phase 2 Unknown
200 enrolled
Genitourinary

Prostatic Neoplasms

NCT00003734 2016-07-21

Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
276 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡